A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
Condition(s):Hepatitis C Viral; Chronic Kidney Disease stage3Last Updated:June 3, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Hepatitis C Viral; Chronic Kidney Disease stage3Last Updated:June 3, 2019Completed
Condition(s):Drug Interaction PotentiationLast Updated:March 13, 2019Completed
Condition(s):Chronic HCV InfectionLast Updated:October 1, 2020Completed
Condition(s):Hepatitis C, ChronicLast Updated:November 20, 2020Completed
Condition(s):Chronic Hepatitis C Genotype 1B; Metabolic Syndrome; Fibrosis, Liver; Cirrhoses, LiverLast Updated:August 7, 2017Unknown status
Condition(s):Hepatitis CLast Updated:December 2, 2017Unknown status
Condition(s):Chronic Hepatitis CLast Updated:December 20, 2018Completed
Condition(s):Hepatitis CLast Updated:March 9, 2020Terminated
Condition(s):Chronic Hepatitis c; Liver Transplant Infection; Kidney Transplant InfectionLast Updated:March 16, 2021Terminated
Condition(s):Acute Hepatitis C; Human Immunodeficiency Virus; Hepatitis CLast Updated:July 8, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.